Zoetis | ZTS - Assets


Zoetis reported $15.08B in Assets for its fiscal quarter ending in June of 2026.





Assets Change Date
AbbVie USD 135.12B 1.35B Jun/2026
Align Technology USD 6.52B 103.03M Sep/2026
Bayer EUR 107.29B 659M Jun/2026
Bristol-Myers Squibb USD 88.77B 1.14B Sep/2026
Charles River Laboratories USD 7.53B 198.16M Jun/2026
Coherus Biosciences USD 191.18M 74.84M Jun/2026
Dentsply International USD 5.2B 25M Jun/2026
Eli Lilly USD 148.07B 5.79B Sep/2026
Henry Schein USD 11.38B 77M Jun/2026
Idexx Laboratories USD 3.71B 264.77M Sep/2026
Illumina USD 6.81B 162M Sep/2026
IQVIA Holdings USD 30.47B 593M Sep/2026
J&J USD 197.42B 3.64B Sep/2026
Laboratory Of America USD 18.92B 392.3M Sep/2026
Merck USD 129.8B 1.12B Jun/2026
Neogen USD 3.3B 42.8M Jun/2026
Pacira USD 1.24B 35.44M Jun/2026
Perrigo USD 7.61B 373.8M Jun/2026
Pfizer USD 201.13B 6.49B Jun/2026
Phibro Animal Health USD 1.5B 56.12M Jun/2026
Quest Diagnostics USD 17.22B 282M Sep/2026
Sanofi EUR 130.29B 1.23B Sep/2026
Sanofi EUR 129.06B 1.04B Jun/2026
Zoetis USD 15.08B 77M Jun/2026